| Breakdown | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 235.90B | 239.89B | 265.46B | 258.10B | 229.12B |
| Gross Profit | 51.90B | 48.84B | 55.84B | 60.39B | 52.26B |
| EBITDA | 27.43B | 25.23B | 31.35B | 35.41B | 31.66B |
| Net Income | 5.25B | 3.35B | 6.47B | 12.24B | 9.99B |
Balance Sheet | |||||
| Total Assets | 331.30B | 334.76B | 370.32B | 357.46B | 319.31B |
| Cash, Cash Equivalents and Short-Term Investments | 32.20B | 34.26B | 34.62B | 36.04B | 41.77B |
| Total Debt | 86.32B | 94.36B | 114.16B | 102.60B | 91.94B |
| Total Liabilities | 157.04B | 170.09B | 200.80B | 201.09B | 181.10B |
| Stockholders Equity | 170.60B | 158.83B | 162.72B | 148.91B | 130.10B |
Cash Flow | |||||
| Free Cash Flow | 9.72B | 19.94B | -4.36B | -8.56B | 19.27B |
| Operating Cash Flow | 17.94B | 31.46B | 12.03B | 11.21B | 33.08B |
| Investing Cash Flow | -5.29B | -7.63B | -17.77B | -20.83B | -14.17B |
| Financing Cash Flow | -15.91B | -24.36B | 3.13B | 2.11B | -18.61B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥177.37B | 7.03 | ― | 2.33% | 25.95% | 66.92% | |
78 Outperform | ¥283.15B | 25.26 | ― | 1.17% | 29.51% | 48.81% | |
72 Outperform | ¥247.70B | 13.29 | 7.86% | 2.55% | 0.57% | 4.54% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥111.07B | 26.06 | 2.64% | 2.30% | -4.11% | 46.76% | |
57 Neutral | ¥367.10B | 15.50 | 11.46% | 3.77% | -9.34% | 164.21% | |
52 Neutral | ¥205.05B | 85.52 | -4.83% | 3.08% | -3.18% | -531.48% |